Erminio Costa
University of Illinois
Department of Psychiatry
Chicago
Illinois 60612
USA
Name/email consistency: high
- Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Costa, E., Dong, E., Grayson, D.R., Guidotti, A., Ruzicka, W., Veldic, M. Epigenetics (2007)
- A GABAergic cortical deficit dominates schizophrenia pathophysiology. Costa, E., Davis, J.M., Dong, E., Grayson, D.R., Guidotti, A., Tremolizzo, L., Veldic, M. Crit. Rev. Neurobiol (2004)
- GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Costa, E., Grayson, D.R., Mitchell, C.P., Tremolizzo, L., Veldic, M., Guidotti, A. Crit. Rev. Neurobiol (2003)
- Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?. Costa, E., Grayson, D.R., Guidotti, A. Mol. Interv. (2003)
- The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Costa, E., Davis, J., Pesold, C., Tueting, P., Guidotti, A. Curr. Opin. Pharmacol (2002)
- GABAA receptors and benzodiazepines: a role for dendritic resident subunit mRNAs. Costa, E., Auta, J., Grayson, D.R., Matsumoto, K., Pappas, G.D., Zhang, X., Guidotti, A. Neuropharmacology (2002)
- REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Costa, E., Chen, Y., Davis, J., Dong, E., Noh, J.S., Tremolizzo, L., Veldic, M., Grayson, D.R., Guidotti, A. Mol. Interv. (2002)
- From GABAA receptor diversity emerges a unified vision of GABAergic inhibition. Costa, E. Annu. Rev. Pharmacol. Toxicol. (1998)